These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 29162926

  • 1. The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension.
    Huang YQ, Jie LI, Chen JY, Tang ST, Huang C, Feng YQ.
    J Hum Hypertens; 2017 Dec; 32(1):40-45. PubMed ID: 29162926
    [Abstract] [Full Text] [Related]

  • 2. Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension.
    Yavuzer H, Cengiz M, Yavuzer S, Rıza Altıparmak M, Korkmazer B, Balci H, Yaldıran AL, Uzun H.
    J Hum Hypertens; 2016 Jul; 30(7):424-9. PubMed ID: 26040439
    [Abstract] [Full Text] [Related]

  • 3. Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.
    Yavuzer S, Yavuzer H, Cengiz M, Erman H, Altıparmak MR, Korkmazer B, Balci H, Simsek G, Yaldıran AL, Karter Y, Uzun H.
    J Hum Hypertens; 2015 Feb; 29(2):92-8. PubMed ID: 25007999
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of serum sCD40L and homocysteine levels with subclinical atherosclerosis indicators in patients with psoriasis: a pilot study.
    Erturan I, Köroğlu BK, Adiloğlu A, Ceyhan AM, Akkaya VB, Tamer N, Başak PY, Korkmaz S, Ersoy IH, Kilinç O.
    Int J Dermatol; 2014 Apr; 53(4):503-9. PubMed ID: 24673360
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of protein oxidation on sustained and white coat hypertension.
    Yıldırım E, İpek E, Bavunoğlu I, Yıldırım N, Cengiz M, Yavuzer S, Yavuzer H, Erman H, Uzun H.
    Anatol J Cardiol; 2017 Mar; 17(3):210-216. PubMed ID: 27684518
    [Abstract] [Full Text] [Related]

  • 7. Elevated circulating sST2 associated with subclinical atherosclerosis in newly diagnosed primary hypertension.
    Ates I, Ozkayar N, Ates H, Karakulak UN, Kursun O, Topcuoglu C, Inan B, Yilmaz N.
    Hypertens Res; 2016 Jul; 39(7):513-8. PubMed ID: 26911231
    [Abstract] [Full Text] [Related]

  • 8. Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension.
    Cengiz M, Yavuzer S, Kılıçkıran Avcı B, Yürüyen M, Yavuzer H, Dikici SA, Karataş ÖF, Özen M, Uzun H, Öngen Z.
    Clin Exp Hypertens; 2015 Jul; 37(8):643-9. PubMed ID: 26114349
    [Abstract] [Full Text] [Related]

  • 9. White-Coat Isolated Systolic Hypertension Is a Risk Factor for Carotid Atherosclerosis.
    Manios E, Michas F, Stamatelopoulos K, Koroboki E, Lykka A, Vettou C, Vemmos K, Zakopoulos N.
    J Clin Hypertens (Greenwich); 2016 Nov; 18(11):1095-1102. PubMed ID: 27480205
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients.
    Alioglu E, Turk UO, Bicak F, Tengiz I, Atila D, Barisik V, Ercan E, Akin M.
    Clin Res Cardiol; 2008 Jul; 97(7):457-62. PubMed ID: 18347767
    [Abstract] [Full Text] [Related]

  • 11. Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients.
    Katakami N, Kaneto H, Matsuhisa M, Miyatsuka T, Sakamoto K, Kawamori D, Yoshiuchi K, Nakamura Y, Kato K, Yamamoto K, Kosugi K, Hori M, Yamasaki Y.
    Diabetologia; 2006 Jul; 49(7):1670-6. PubMed ID: 16752185
    [Abstract] [Full Text] [Related]

  • 12. C-reactive protein and nitric oxide level in patients with white coat hypertension.
    Guven A, Tolun F, Caliskan M, Ciftci O, Muderrisoglu H.
    Blood Press; 2012 Oct; 21(5):281-5. PubMed ID: 22229480
    [Abstract] [Full Text] [Related]

  • 13. Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease.
    Desideri G, Cipollone F, Valeri L, Grassi D, Necozione S, Croce G, Passacquale G, Garofalo A, Lippi C, Mezzetti A, Ferri C.
    Am J Hypertens; 2007 Jan; 20(1):70-6; discussion 77. PubMed ID: 17198914
    [Abstract] [Full Text] [Related]

  • 14. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A, Chung I, Panja N, Patel J, Lip GYH.
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [Abstract] [Full Text] [Related]

  • 15. Impaired systolic blood dipping and nocturnal hypertension: an independent predictor of carotid intima-media thickness in type 1 diabetic patients.
    Atabek ME, Akyürek N, Eklioglu BS, Alp H.
    J Diabetes Complications; 2014 Sep; 28(1):51-5. PubMed ID: 24157221
    [Abstract] [Full Text] [Related]

  • 16. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S, Demir M, Arikan E, Turgut B, Azcan S, Gerenli M, Tugrul A.
    Thromb Res; 2007 Sep; 119(1):79-84. PubMed ID: 16476470
    [Abstract] [Full Text] [Related]

  • 17. Soluble ligand CD40 and uric acid as markers of atheromatosis in patients with obstructive sleep apnea.
    Kosacka M, Brzecka A, Piesiak P, Korzeniewska A, Jankowska R.
    Adv Exp Med Biol; 2015 Sep; 839():55-60. PubMed ID: 25315617
    [Abstract] [Full Text] [Related]

  • 18. Subclinical Atherosclerosis in Patients with Prior Pulmonary Thromboembolism.
    Buyukterzi Z, Buyukterzi M, Kurtipek E, Alpaydin MS, Karaarslan S.
    Med Princ Pract; 2017 Sep; 26(4):321-324. PubMed ID: 28380485
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.
    Yurtdaş M, Yaylali YT, Kaya Y, Ozdemir M, Ozkan I, Aladağ N.
    Echocardiography; 2014 Oct; 31(9):1095-104. PubMed ID: 24447343
    [Abstract] [Full Text] [Related]

  • 20. Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?
    Kurt T, Temiz A, Gokmen F, Adam G, Ozcan S, Ozbudak E, Sacar M.
    Wien Klin Wochenschr; 2015 Jul; 127(13-14):529-34. PubMed ID: 25777147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.